Discuss This Drug

rifamycin SV

CHEBI:CHEBI_29673

Definition

A member of the class of rifamycins that exhibits antibiotic and antitubercular properties.

Chemical Information

Molecular Formula
C37H47NO12
Molecular Mass
697.76860
Charge
0
SMILES
CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)cc(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(O)c2c(O)c3C
InChI
InChI=1S/C37H47NO12/c1-16-11-10-12-17(2)36(46)38-23-15-24(40)26-27(32(23)44)31(43)21(6)34-28(26)35(45)37(8,50-34)48-14-13-25(47-9)18(3)33(49-22(7)39)20(5)30(42)19(4)29(16)41/h10-16,18-20,25,29-30,33,40-44H,1-9H3,(H,38,46)/b11-10+,14-13+,17-12-/t16-,18+,19+,20+,25-,29-,30+,33+,37-/m0/s1
InChIKey
HJYYPODYNSCCOU-ODRIEIDWSA-N

Alternative Names

  • rifamycin
  • (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
  • rifamicina
  • Rifamycin
  • Rifamycin SV
  • rifamycine
  • rifamycinum
  • Rifocin
  • Rifocyn

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
35616
oboInOwl#hasDbXref
Reaxys:5401012
core#notation
CHEBI:29673

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
35616
oboInOwl#hasDbXref
Reaxys:5401012
oboInOwl#id
CHEBI:29673
core#notation
CHEBI:29673
generic_name
RIFAMYCIN SODIUM
rxcui
2106362
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
route
ORAL
listing_expiration_date
20241231
dosage_form
TABLET, DELAYED RELEASE
marketing_start_date
20120621
package_marketing_start_date
21-JUN-12
active_ingredient_strength
194 mg/1
labeler_name
RedHill Biopharma Ltd
active_ingredient_name
RIFAMYCIN SODIUM
product_ndc
57841-1201
spl_id
617f8703-f6a2-7afd-e053-2a91aa0ae9af
package_ndc
57841-1201-1
package_description
1 BLISTER PACK in 1 CARTON (57841-1201-1) / 4 TABLET, DELAYED RELEASE in 1 BLISTER PACK (57841-1201-0)
nui
M0019113
pharm_class_epc
Rifamycin Antibacterial [EPC]
pharm_class
Rifamycins [CS]
pharm_class_cs
Rifamycins [CS]
manufacturer_name
RedHill Biopharma Ltd
brand_name
Aemcolo
brand_name_base
Aemcolo
application_number
NDA210910
unii
DU69T8ZZPA
spl_set_id
b31ff668-ee1f-4d89-8b69-68df2a0d2243
upc
0357841120016
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_76969
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#is_conjugate_acid_of
http://purl.obolibrary.org/obo/CHEBI_84571
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_110636
chebi#is_conjugate_base_of
http://purl.obolibrary.org/obo/CHEBI_84571
owl#annotatedSource
t173278
owl#someValuesFrom
t3349551